Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.69 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.69 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.69 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.67 |
| ▸ | TP53 | P04637 | 4/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.67 |
| ▸ | MEN1 | O00255 | 3/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.67 |
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.67 |
| ▸ | THPO | P40225 | 2/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.67 |
| ▸ | FPR2 | P25090 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6361662 | 1.00 | HDAC4 (0.69) | HDAC4HDAC10HDAC6HDAC5CYP3A4 | |
| SCHEMBL17312330 | 1.00 | HDAC4 (0.69) | HDAC4HDAC10HDAC6HDAC5CYP3A4 | |
| SCHEMBL29729303 | 1.00 | HDAC4 (0.69) | HDAC4HDAC10HDAC6HDAC5CYP3A4 | |
| SCHEMBL107807 | 1.00 | HDAC4 (0.69) | HDAC4HDAC10HDAC6HDAC5CYP3A4 | |
| SCHEMBL5384708 | 0.99 | HDAC4 (0.67) | HDAC4HDAC10HDAC6HDAC5CYP3A4 | |
| SCHEMBL28265897 | 0.95 | HDAC4 (0.64) | HDAC4HDAC10HDAC6HDAC5CYP3A4 | |
| SCHEMBL8488157 | 0.95 | HDAC4 (0.65) | HDAC4HDAC10HDAC6HDAC5CYP3A4 | |
| SCHEMBL28267305 | 0.94 | CYP3A4 (0.63) | HDAC4HDAC10HDAC6HDAC5CYP3A4 | |
| SCHEMBL4126349 | 0.94 | HDAC4 (0.62) | HDAC4HDAC10HDAC6HDAC5CYP3A4 | |
| SCHEMBL4142506 | 0.93 | HDAC4 (0.77) | HDAC4HDAC10HDAC6HDAC5CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2772 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3411059-B1 | METHOD TO ENHANCE THE EFFICIENCY OF SYSTEMIC AAV GENE DELIVERY TO THE CENTRAL NERVOUS SYSTEM | UNIV MASSACHUSETTS (US) | 2026-05-06 | — | — | EP | claimed |
| US-12396965-B2 | Putrescine topical barrier formulation | VIVIER CANADA INC. (CA) | 2025-08-26 | — | — | US | claimed |
| CN-113454099-B | Detection of colonography in vivo using near infrared peptides targeting over-expression of cMET | 密歇根大学董事会 | 2025-05-27 | — | — | CN | claimed |
| US-20250067753-A1 | Protein array-based in vitro transglutaminase assay platform for epitope mapping and immunogen design | LIU CHEN (US) | 2025-02-27 | — | — | US | claimed |
| US-20240293340-A1 | PUTRESCINE TOPICAL BARRIER FORMULATION | VIVIER CANADA INC. (CA) | 2024-09-05 | — | — | US | claimed |
| US-20240216329-A1 | PUTRESCINE TOPICAL FORMULATIONS | VIVIER CANADA INC. (CA) | 2024-07-04 | — | — | US | claimed |
| US-20240197677-A1 | PUTRESCINE SLOW-RELEASE TOPICAL FORMULATIONS | VIVIER CANADA INC. (CA) | 2024-06-20 | — | — | US | claimed |
| US-20230392186-A1 | METHOD AND DEVICE FOR DETECTING TRANSGLUTAMINASES | Technische Universität Darmstadt (DE) | 2023-12-07 | — | — | US | claimed |
| EP-4286528-A1 | METHOD AND DEVICE FOR DETECTING TRANSGLUTAMINASES | Technische Universität Darmstadt (DE) | 2023-12-06 | — | — | EP | claimed |
| US-11826433-B2 | Method to enhance the efficiency of systemic AAV gene delivery to the central nervous system | UNIVERSITY OF MASSACHUSETTS (US) | 2023-11-28 | — | — | US | claimed |
| WO-2009038289-A2 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING FIBROSIS | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2009-03-26 | — | — | WO | claimed |
| US-7090987-B1 | Methods for the identification of compounds for the treatment of neuronal atrophy-associated dementia | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-08-15 | — | — | US | claimed |
| EP-0754189-B1 | RECEPTOR MODULATING AGENTS AND METHODS RELATING THERETO | RECEPTAGEN CORP (US) | 2002-10-09 | — | — | EP | claimed |
| US-6322996-B1 | REACTING A PHYSIOLOGICALLY ACTIVE PROTEIN WITH AN AMINO GROUP DONOR OR ALKYLAMINE-CONTAINING POLYSACCHARIDE IN PRESENCE OF TRANSGLUTAMINASE, THEREBY MODIFYING PROTEIN BY FORMING AN AMIDO LINKAGE BETWEEN CARBOXYAMIDE GROUP OF GLUTAMINE RESIDUE | DRUG DELIVERY SYSTEM INSTITUTE, LTD. (JP) | 2001-11-27 | — | — | US | claimed |
| WO-1998004245-A1 | USE OF TRANSGLUTAMINASE MODULATORS TO PROMOTE WOUND HEALING | THE VICTORIA UNIVERSITY OF MANCHESTER (GB) | 1998-02-05 | — | — | WO | claimed |
| EP-0725145-A1 | METHOD OF MODIFYING PROTEIN | DRUG DELIVERY SYSTEM INSTITUTE, LTD. (JP) | 1996-08-07 | — | — | EP | claimed |
| US-5541633-A | Ink jet printing of concealed images on carbonless paper | XEROX CORPORATION (US) | 1996-07-30 | — | — | US | claimed |
| US-5308774-A | Deproteinization, transferring and desorption | HITACHI, LTD. (JP) | 1994-05-03 | — | — | US | claimed |
| US-5286286-A | Containing diethylene glycol monobutyl ether, glycerol, and a dansyl or porphyrin chromophores | XEROX CORPORATION (US) | 1994-02-15 | — | — | US | claimed |
| WO-1991010427-A2 | THE EFFECT OF TRANSGLUTAMINASE INHIBITION ON MICROFILARIAE DEVELOPMENT AND MACROFILARIAE VIABILITY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-07-25 | — | — | WO | claimed |